16560-18-2

Upstream product

• 100-52-7 benzaldehyde 
• 62-53-3 aniline 
• 105-34-0 methyl 2-cyanoacetate 
• 15000-43-8 2,4-dihydroxyquinoline-3-carbonitrile 
• 680210-85-9 4-chloro-2-oxo-1,2-dihvdroquinoline-3-carbonitrile 
• 98-80-6 phenylboronic acid 
• 69875-54-3 2,4-Dichloroquinoline-3-carbonitrile 
• 118-48-9 isatoic anhydride 

Downstream Products

• 1426831-81-3 C₁₉H₁₅ClN₂O 
• 1426831-82-4 C₁₉H₁₅ClN₂O 

Relevant academic research and scientific papers

PHENYL-CYANOQUINOLINONE PDE9 INHIBITORS

The present invention is directed to phenylcyanoquinolinone compounds which may be useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 9 (PDE9). The present invention also relates to the use

TiO2 nanopowder catalyzed microwave-induced one-pot synthesis of novel quinoline/benzo[h]quinoline3-carbonitrile under solvent free conditions

A rapid and efficient method for the synthesis of various carbonitrile quinoline/benzo[h]quinolines has been developed through the Knoevenagel condensation, Michael addition of aromatic aldehyde/amine with carbonyl compounds in the presence of a nanostruc

1,2-Dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives

1,2-Dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives are provided having the structure STR1 wherein (CH2)n represents a straight chain alkylene group containing 2 to 5 carbons, and R1 and R2 are the sa